Premier Research Labs, Premier Vegan D3+K2, 60 Plant-Source Capsules
UPC Code: 807735712105
Description
Premier Vegan D3+K2 is a high-potency, plant-based supplement delivering clinically relevant levels of vitamin D3 and vitamin K2 (as MK-7, the preferred form) to support bone health, calcium metabolism, and cardiovascular function.
Each capsule provides 5,000 IU (125 mcg) of vitamin D3 and 180 mcg of vitamin K2 derived from fermented natto, one of the most bioavailable forms of K2 available.
Premier Vegan D3+K2 is formulated without fillers, additives, or synthetic excipients. The clean, powder-based capsules are a great choice for those seeking a vegan-friendly, gluten-free formula backed by rigorous purity, heavy metal, and microbiological testing.
Packaging
60 Plant-Source Capsules
Suggested Use
Take 1 capsule daily or as directed by a health care professional.
About Premier Research Labs
For many years, Premier Research Labs has had a sterling reputation as the world's leader in cellular resonant nutrition technology. We have strived to become the industry leader in excipient-free, preservative-free, premier quality nutritional products and super foods.
Far from obtaining ingredients from the "cheapest on the market," PRL sources its raw materials from trusted suppliers all over the world using our strict purity protocols that we have developed to consistently ensure the premier quality that is the foundation of all our products. In addition, our comprehensive practitioner line of clinically tested nutritional products includes the first targeted organ and gland formulas.
Safety
Do not use if pregnant or nursing. Keep out of reach of children. Please consult your health care provider if currently under care or treatment. Do not exceed recommended serving. See product packaging for additional safety information.
Disclaimer
Individual results may vary. This product is not intended to diagnose, treat, cure or prevent any disease. The statements on this website and all affiliates have not been evaluated by the FDA. Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner.